NCT03444792

Brief Summary

obstetric hemorrhage remains one of the major causes of maternal death in both developed and developing countries. Because of its importance as a leading cause of maternal mortality and morbidity, and because of evidence of substandard care in the majority of fatal cases, obstetric hemorrhage must be considered as a priority topic for national guideline development. Some obstetricians believe that the cervix of women at non-labor cesarean section is undilated and might cause obstruction of blood or lochia drainage, leading to postpartum hemorrhage and endometritis from the collection of lochia or debris. Dilatation of the cervix helps with the drainage of blood during postpartum, reducing intrauterine infection or the risk of postpartum hemorrhage. To avoid this problem, some obstetricians routinely dilate the cervix from above during an elective/ non-labor cesarean section using finger, sponge forceps or other instruments

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
774

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2018

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

February 19, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 23, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2018

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2018

Completed
Last Updated

July 6, 2018

Status Verified

July 1, 2018

Enrollment Period

4 months

First QC Date

February 19, 2018

Last Update Submit

July 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Vaginal bleeding during the 1st 24 hours postoperative.

    The amount of vaginal bleeding will be calculated according to number of soaked pads used after the cesarean section for the 1st 24 hours. Where each soaked pad = 50 cc

    the 1st 24 hours postoperative.

Secondary Outcomes (2)

  • intraoperative blood loss

    during the time of the operation

  • Total blood loss

    operation time plus the 1st 24 hours after operation

Study Arms (2)

Group I (dilation group)

EXPERIMENTAL

the surgeon will perform the cervical dilatation by inserting the double-gloved index finger into the cervical canal of the patients after the extraction of placenta and membranes. The outer glove will be removed after this procedure. - If failed we will use artery forceps to dilate cervix

Procedure: mechanical dilatation of the cervix

Group II (non dilatation group)

NO INTERVENTION

the surgeon will perform cesarian section without attempting cervical dilatation

Interventions

the surgeon will perform the cervical dilatation by inserting the double-gloved index finger into the cervical canal of the patients after the extraction of placenta and membranes. The outer glove will be removed after this procedure. \- If failed the surgeon will use artery forceps to dilate cervix

Group I (dilation group)

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • pregnant women with a single term fetus \>37 weeks of gestational age, with American Society of Anesthesiology (ASA) physical status I or II undergoing Elective Cs (primary or repeated CS).
  • Age group 20 - 35 years old

You may not qualify if:

  • Chorioamnionitis.
  • Placenta previa.
  • Multiple gestations.
  • Preeclampsia.
  • Macrosomia.
  • Hydramnios.
  • Uterine leiomyomata.
  • Anemia.
  • Previous cervical surgery.
  • Previous post-partum hemorrhage.
  • Bleeding tendency.
  • Hypertension.
  • Diabetes mellitus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Cairo University

Cairo, 11231, Egypt

Location

MeSH Terms

Conditions

Postoperative Hemorrhage

Condition Hierarchy (Ancestors)

HemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsPostoperative Complications

Study Officials

  • mohamed sharkawy, assis.prof.

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The included patients will be randomized using sealed opaque envelope method into two groups
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Prospective randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer in obstetrics and gynecology

Study Record Dates

First Submitted

February 19, 2018

First Posted

February 23, 2018

Study Start

February 10, 2018

Primary Completion

June 15, 2018

Study Completion

June 20, 2018

Last Updated

July 6, 2018

Record last verified: 2018-07

Locations